Cargando…
Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation
Cancer stem cells (CSCs) are responsible for tumor initiation and progression. We previously showed that Delta-like homolog 1 (DLK1) may be a therapeutic target against the CSCs of human hepatocellular carcinoma (HCC). However, the therapeutic efficacy and underlying mechanism remain unclear. Here w...
Autores principales: | Cai, Chun-Miao, Xiao, Xu, Wu, Bing-Hao, Wei, Bao-Feng, Han, Ze-Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342093/ https://www.ncbi.nlm.nih.gov/pubmed/27683116 http://dx.doi.org/10.18632/oncotarget.12214 |
Ejemplares similares
-
Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects
por: Yang, Hao, et al.
Publicado: (2018) -
Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation
por: Bort, Alicia, et al.
Publicado: (2017) -
Resveratrol exerts antitumor effects by downregulating CD8(+)CD122(+) Tregs in murine hepatocellular carcinoma
por: Zhang, Qunfang, et al.
Publicado: (2020) -
Loss of Imprinting and Allelic Switching at the DLK1-MEG3 Locus in Human Hepatocellular Carcinoma
por: Anwar, Sumadi Lukman, et al.
Publicado: (2012) -
DLK makes neuronal cutbacks
por: Short, Ben
Publicado: (2011)